Patients with PsA have a higher prevalence of MetS compared with members of the general population and individuals with other inflammatory arthropathies.

Many studies have examined how rheumatoid arthritis therapy affects the risk of metabolic comorbidities. Though metabolic disruption can have significant long-term adverse outcomes for people with ...

Results of a systematic review and meta-analysis point to higher rates of metabolic syndrome among patients with psoriatic arthritis. MetS is defined as a cluster of metabolic abnormalities, including ...

A study presented at ACR Convergence 2025 has sparked interest among doctors and patients alike. Drugs originally made for ...

A new study led by Swansea University has revealed a new way to potentially treat certain autoimmune diseases by targeting a ...

Inflammatory arthritis resulting from immune checkpoint inhibitor use is immunologically unique and likely driven by T cells ...

New research presented at ACR 2025 shows GLP-1 receptor agonists, used for diabetes and obesity, may reduce rheumatoid ...

There are many different types of arthritides. The most common of these is osteoarthritis, a degenerative form. Many people ...

Read by invitation before the American Psychopathological Association, May 18, 1935, in Washington, D. C. Nissen, H. Archibald — Member of the Staff and Visiting Physician, New England Deaconess ...

Preclinical data highlight MTHFD2 as a promising metabolic target in autoimmune disease, providing strong validation for the advancement of ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Rheumatoid Arthritis Market Report: 2016 Edition" report to their offering. Arthritis means inflammation in a ...